Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease. Recursion applies causative perturbations to human cells to generate disease models and associated biological image data. Recursion’s rich, relatable database of more than a petabyte of biological images generated in-house on the company’s robotics platform enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics to radically improve lives. Recursion is headquartered in Salt Lake City.
Looking for a particular Recursion Pharmaceuticals employee's phone or email?
The Recursion Pharmaceuticals annual revenue was $48.6 million in 2026.
Najat Khan is the Chief Executive Officer and President | Member, Board of Directors of Recursion Pharmaceuticals.
564 people are employed at Recursion Pharmaceuticals.
Recursion Pharmaceuticals is based in Salt Lake City, Utah.
The NAICS codes for Recursion Pharmaceuticals are [32541, 325, 32, 3254].
The SIC codes for Recursion Pharmaceuticals are [283, 28].